TGA-pathway international supply: how Australian importers source Thai-origin medical cannabis

Why this brief exists alongside the TGA pathway post

The existing CannaBless brief on the TGA pathway is patient and prescriber facing — it explains how the Therapeutic Goods Administration governs prescription medical cannabis in Australia through the Special Access Scheme (SAS) and Authorised Prescriber frameworks. This brief is the importer-side counterpart: what an Australian licensed importer expects from an international cultivator, and how the Thai documentation stack maps onto Australian regulatory requirements.

The two-licence structure: TGA + ODC

Every Australian import of medical cannabis sits under two regulators operating in parallel:

1. Therapeutic Goods Administration (TGA). Issues the manufacturing or importation licence under the Therapeutic Goods Act 1989 and governs whether a product can be supplied as a therapeutic good in Australia. For internationally sourced flower, this is the importer's licence that allows them to bring product into the country for downstream supply to pharmacies under SAS-B prescriptions or Authorised Prescriber arrangements.
2. Office of Drug Control (ODC). Sits within the Department of Health and Aged Care and issues controlled-drug permits under the Narcotic Drugs Act 1967. Cannabis is a Schedule 8 controlled drug in Australia, so every individual shipment requires an ODC import permit naming the consignor, consignee, quantity, and product form.

The licensed Australian importer holds both. The international cultivator does not — the cultivator supplies into the importer, who then assumes the Australian regulatory burden.

Cultivator-side documentation expectation

The documentation pack the Australian importer expects from the international cultivator is the standard regulated-market list:

• GACP cultivation certification from the exporting country (TH-GACP for Thailand, demonstrating compliance with the national Good Agricultural and Collection Practices standard)
• Full Certificate of Analysis from an ISO/IEC 17025 accredited laboratory — cannabinoid profile, terpenes, microbial, pesticides, heavy metals — issued per batch with the batch identifier
• Certificate of Origin from the exporting country
• Phytosanitary Certificate from the exporting country's plant- health authority
• Country-of-origin export permit specific to the shipment, with the Australian importer's licence cited
• Cold-chain shipping documentation showing continuous 15-18 °C reefer-container conditions with humidity logging from harvest through to Australian port of entry

The Australian importer combines this with their own ODC import permit application, which is shipment-specific and references the cultivator- side documentation directly.

Avicanna's March 2026 Colombia → AU CBG export — the precedent

In March 2026, the Colombian subsidiary of Canadian-listed Avicanna completed the first CBG (cannabigerol) export to Australia through the standard TGA / ODC pathway. The shipment cleared without requiring exceptional procedures — it followed the same import-licence and ODC permit framework that established Canadian and European suppliers operate under.

The structural significance for Thai-origin cultivators is direct:

• Tropical-latitude origin is accepted. Colombia and Thailand are the same equatorial-latitude category. The TGA acceptance of Colombian-origin product implies that origin geography is not the barrier.
• Non-Canadian origin is accepted. Avicanna chose to ship from Colombia rather than its Canadian capacity. The TGA workflow treats the documentation, not the origin reputation, as the qualifying criterion.
• Non-THC cannabinoid still subject to full Schedule 8 process. The CBG product still required ODC permit and TGA importation licence — confirming that the procedural pathway is the same one Thai flower would follow.

For an Australian importer evaluating Thai-origin supply, Avicanna's clearance is the recent, citable, third-party precedent.

Mapping Thai documentation onto TGA import requirements

The Thai legal-export documentation pack maps cleanly onto Australian expectations because both pathways evolved from the same UN Single Convention on Narcotic Drugs framework. The mapping is:

• TH-GACP → satisfies TGA's GACP equivalence expectation
• Thai MOPH / ONCB export licence → fulfills the "country-of-origin export permit" requirement on the ODC import-permit application
• ISO/IEC 17025 Certificate of Analysis → satisfies TGA's product-quality and batch-release evidence requirements
• Phytosanitary Certificate (Thailand DOA) → fulfills standard agricultural-product import requirement
• Certificate of Origin (Thailand) → fulfills customs and TGA origin-declaration requirements

No bespoke Thai-specific documentation is needed; the standard Thai export pack is structurally complete for Australian import.

How CannaBless approaches Australian supply conversations

CannaBless is a Thailand-based cultivator-side B2B exporter. We hold the Thai legal export licence (MOPH / ONCB) and supply licensed Australian importers operating under TGA + ODC frameworks. We do not sell directly to Australian patients, clinics, or pharmacies — that is the Australian importer's commercial domain.

The Italian shipment under permit IT-20261155773424 — 700 kg arriving Genova in June 2026, receipted by AL.MA. SRL — is the structurally identical EU-side proof anchor. The same documentation pack, the same cold-chain procedures, the same per-batch testing discipline produce the same outcome for an Australian importer.

Next step

If you are an Australian licensed importer evaluating Thai-origin supply for SAS-B or Authorised Prescriber programmes, the export desk responds within one business day from Bangkok (UTC+7). WhatsApp is the fastest channel; email is fine for documentation-heavy enquiries.